Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

17 results about "Order Rodentia" patented technology

Rodents (from Latin rodere, "to gnaw") are mammals of the order Rodentia, which are characterized by a single pair of continuously growing incisors in each of the upper and lower jaws.

Genetically modified rodents for preparing common light chain and methods of making same

PendingCN121592712ABlood/immune system cellsFused cellsHuman immunoglobulinsImmunoglobulin light chain locus
The present invention discloses a genetically modified rodent whose immunoglobulin light chain locus is modified so as to comprise a single rearranged human immunoglobulin light chain gene V / J gene upstream of a mouse Kappa light chain locus constant region, a mouse variable region sequence cannot bind to an endogenous constant region to form a complete mouse light chain antibody, the rodents are capable of normally reproducing and producing human light chain-containing antibodies. The invention also provides a method of making the genetically modified rodent and a use of the rodent.
Owner:CYAGEN BIOSCIENCES (SUZHOU) INC

Device for protecting a rodenticide bait in a sewer

Device (1) for providing a rodenticide bait in a sewer, comprising a holding device (17) for receiving a bait, wherein the bait is freely accessible to rodents in a first position of the device (1), a protective device (7) designed to at least partially enclose the bait, a release mechanism actuated by a rising water level, wherein the protective device (7) is held in an open position in the first position by a retaining element (15), and wherein the release mechanism comprises a float (6) which releases the retaining element (15) when the water level rises, so that the protective device (7) is automatically moved into a closed position in which the bait is shielded from the surrounding water.
Owner:ALTENDORF PAUL +1

Transgenic mammals and methods of use thereof

PendingJP2026026076ANucleic acid vectorBlood/immune system cellsTherapeutic antibodyImmunoglobulin light chain
To provide transgenic mammals expressing bovine-based immunoglobulins, including transgenic rodents expressing bovine-based immunoglobulins for the development of bovine therapeutic antibodies.SOLUTION: A transgenic rodent or rodent cell is provided comprising an engineered partially bovine immunoglobulin light chain locus comprising bovine immunoglobulin λ light chain variable region gene segments, wherein the engineered immunoglobulin locus is capable of expressing immunoglobulins comprising bovine variable domains, and wherein the transgenic rodent produces or is likely to produce more immunoglobulins comprising λ light chains than immunoglobulins comprising κ light chains.SELECTED DRAWING: Figure 13
Owner:TRIANNI INC

Live catch rodent trap

A live catch rodent trap comprises a housing, an entry door, a release or exit door, and a latch assembly. The housing defines a first or entry opening, and a second or release opening. The entry door selectively covers the first opening, enabling a rodent to enter an interior of the trap and to be captured therewithin. The release door is pivotally attached to the housing. The release door is, in response to actuation by a user, movable between a closed position covering the second opening, and a release position at least partially uncovering the second opening and permitting a rodent to exit the interior of the trap. The latch assembly selectively secures the release door in the closed position, and includes an actuator adapted to be engaged or biased by a user for releasing the latch assembly from a latched state.
Owner:WOODSTREAM CORP

Pest trap with a seesaw located in the entrance area

A pest trap (1), in particular for controlling rodents, comprising a base body with an interior (3) and an entrance opening (4) leading into the interior (3), wherein a rocker (5) is arranged in the area of ​​the entrance opening (4), which is pivotably mounted about an axis of rotation (8) and has a passage (9) for a rodent and has at least a first rocker side (6) facing the entrance opening (4) with an outer surface (12) that can be walked on by a rodent and a second rocker side (7) facing the interior (3) with an inner surface (11) of the passage (9) that can be walked on by a rodent, wherein the rocker (5) is pivotable between a first position and a second position, and wherein the rocker (5) is operatively connected to a closing element of the entrance opening (4) such that when the walkable inner surface (11) is entered, the rocker (5) is pivoted into the first position.wherein the locking element closes the entrance opening (4), and when the outer surface (12) of the first rocker side (6) is entered, the rocker (5) pivots from the first position to the second position, in which the entrance opening (4) is released by the locking element.
Owner:ALTENDORF PAUL +1

Device and system for controlling rodent pests

ActiveDE202025107515U1ProjectileAnimal trapsVerminOrder Rodentia
Device for controlling rodent pests, comprising a killing agent (6, 7) and a carrier with a carrier surface that rodent pests can walk on, wherein the killing agent (6, 7) is attached to the carrier and defines an effective area extending along a section of the carrier surface frequented by rodents, the killing agent (6, 7) is oriented relative to the carrier in such a way that a rodent killed in the effective area falls away from the carrier surface by gravity and the effective area remains open for a subsequent rodent, and the killing device (6, 7) has at least one triggering device projecting into the effective area, which can be actuated by a rodent crossing the effective area to trigger a killing process, wherein the killing device (6, 7) is switchable between an activated state and a deactivated state.
Owner:KLEINLOGEL BJÖRN

I-type primary hyperoxaluria animal model as well as preparation method and application thereof

The invention provides an I-type primary hyperoxaluria animal model as well as a preparation method and application thereof. Specifically, the invention provides an application of a combination of experimental materials, and the combination is used for preparing a rodent model of type I primary hyperoxaluria (PH1). A mouse model in which 3rd to 8th exons of the Agxt gene are knocked out and a specific dose of glyoxylic acid are used, so that the human disease phenotype of the type I primary hyperoxaluria can be more accurately simulated, the modeling time is greatly shortened, the research cost is reduced, and the method is suitable for popularization and application. The pathogenesis of the PH1 can be better clarified, and the searching of a PH1 immunotherapy target spot and method and the screening of a medicine for treating the PH1 are promoted.
Owner:CHILDRENS HOSPITAL OF FUDAN UNIV

Safe manufacturing process of small rodent high-fidelity ecological specimen

PendingCN122056267ADead animal preservationEducational modelsMouse TongueArtificial Eyes
The invention relates to the technical field of specimen manufacturing, in particular to a safe manufacturing process of a small rodent high-fidelity ecological specimen. Comprising the following steps: taking a mouse corpse, and fixing the mouse corpse on a mouse dissecting disc; dissecting the mouse, taking out organs, cutting off mouse tongues, and releasing muscles; putting the anti-corrosion powder into released muscles of the abdominal cavity, the chest, the oral cavity and the neck of the mouse, and finally filling the mouse with the anti-corrosion powder; tearing the cotton ball into a sheet shape, covering the space between the mouse chest, abdominal cavity, neck preservative powder and skin, sewing, then taking down and inserting on a foam plate, adjusting the shape, and arranging hair; and putting the modeled mouse book into a paper box, pouring anti-corrosion powder, sealing the box, air-drying, taking out the mouse book, wiping off the anti-corrosion powder, installing an artificial eye, displaying and pasting an information label, thereby finishing the manufacturing. The ecological specimen prepared through the method is vivid in form, the operation method is simple, and no chemical hazard or risk exists.
Owner:XIAN CENT FOR DISEASE CONTROL & PREVENTION

Rodent killing apparatus

ActiveUS12543723B2Animal trapsAnimal scienceRodent populations
A rodent control apparatus comprising an elongated tube sized to receive a rodent (e.g., rat, mouse, etc.) at a front portion, electrocute the rodent in a middle portion, and propel the rodent's body toward a rodent disposal bag attached to a rear portion. The apparatus is configured to kill and store the remains of many rodents and, as such, finds great utility within the context of reducing a local rodent population.
Owner:PLAIN JOHN

Rodent nasal mucosa tissue sampling device

The utility model relates to the technical field of rodent nose tissue pathological specimen material taking, specifically discloses rodent nasal mucosa tissue material taking device, the one side of fixed plate is provided with first fixed clamping groove and second fixed clamping groove respectively, is provided with head container on the fixed plate, is provided with first clamping groove insertion port, second clamping groove insertion port and cutting knife clamping groove on head container respectively, and the one side of head container is provided with scale, the rodent nasal mucosa tissue material taking device whole simple structure, and the installation and use are convenient, and the material taking work of rodent nasal mucosa tissue of staff is convenient, since setting up the scale for measuring distance on the bottom plate, a plurality of graduation grooves are opened on the scale, the position of rodent head tissue is measured through the scale, is convenient for its accurate cutting, thereby help to improve the accuracy of rodent nasal mucosa tissue material taking.
Owner:SHANGHAI QIANYA JINGZHI BIOTECHNOLOGY CO LTD

Genetically modified rodents and rodent cells and uses thereof

The present invention relates to transgenic rodents and rodent cells expressing components of the human immune system, and their use in the production of human T cell receptors (TCRs). The present invention relates to a genetically modified rodent comprising a TCR [alpha] locus and a TCR [beta] locus; wherein the TCR alpha gene locus comprises a human TCR alpha variable gene segment and a human TCR alpha constant region which are not rearranged, and the TCR beta gene locus comprises a human TCR beta variable gene segment and a human TCR beta constant region which are not rearranged. The present invention relates to the use of a human TCR transgenic rodent in the generation of antigen-specific CD8 + T cell response for discovering a fully human TCR sequence with therapeutic potential.
Owner:CAMBRIDGE ENTERPRISE LTD

Rodent trap with modulated ceiling structure

PCT designated stageWO2026099580A1ProjectileAnimal trapsStructural engineeringMechanical engineering
The present invention relates to a rodent trap (100) comprising a housing (101) with a passage (104), and a kill mechanism (150) within the housing adjacent to a kill zone (170) of the passage, arranged to be activated by a rodent within the kill zone. A first end of the passage forms a first opening (102) in the surface of the housing, and a second end of the passage forms a second opening (102) in the surface of the housing. The kill mechanism comprises a hammer (160) arranged to move into the kill zone when the kill mechanism is activated to strike a rodent within the kill zone. The ceiling of the passage is shaped such that a height of the ceiling at the kill zone (181) is higher than a height of the ceiling at the first and second openings (182a, 182b) in the surface of the housing.
Owner:RENTOKIL INITIAL 1927 PLC

Rodent model for serpina1 gene correction

PCT designated stageWO2026076372A1Microencapsulation basedEnzymesEfficacyRespiratory agents
Provided herein are humanized rodent models comprising a human SERPINA1 transgene, optionally wherein the rodents develop Alpha- 1 antitrypsin deficiency (A1ATD). Further provided herein are methods related to the use of the humanized rodent models for screening therapeutic efficacy for A1ATD, for example, for screening the efficacy of any treatment selected from the group consisting of liver transplantation, respiratory agents, purified alpha- 1 antitrypsin (A1AT) protein, and gene therapy.
Owner:GENZYME CORP

Genetically modified rodent used for preparing common light chain and preparation method therefor

PCT designated stageWO2026040501A1Hybrid immunoglobulinsVector-based foreign material introductionHuman immunoglobulinsImmunoglobulin light chain locus
Disclosed is a genetically modified rodent an immunoglobulin light chain locus of which is engineered such that a single rearranged human immunoglobulin light chain gene V / J gene is contained upstream of a constant region of the mouse Kappa light chain locus, and thus a mouse variable region sequence cannot bind to the endogenous constant region to form a complete mouse light chain antibody. The rodent can reproduce normally and produce an antibody containing a human light chain. Also provided are a preparation method for the genetically modified rodent and the use thereof.
Owner:CYAGEN BIOSCIENCES (SUZHOU) INC

Rodent traps

UndeterminedES3075697T3Animal scienceTrap door
A rodent trap comprising an activation mechanism designed to be triggered by a rodent, a disposal mechanism designed to kill the rodent upon activation, a trapdoor located adjacent to the disposal mechanism with a closed and an open position, and a storage area located on the other side of the trapdoor with respect to the disposal mechanism. The trap is designed such that when a rodent is killed by the disposal mechanism, its carcass passes through the trapdoor into the storage area.
Owner:RENTOKIL INITIAL 1927 PLC

Rodents expressing humanized polymeric immunoglobulin receptor

PCT designated stageWO2026096736A1Cell receptors/surface-antigens/surface-determinantsNucleic acid vectorMedicinePolymeric immunoglobulin receptor
Provided herein are genetically modified rodents (e.g., mice) comprising a humanized PIGR locus in their genome, for example, positioned at an endogenous mouse PIGR locus. Also provided herein are methods of making and / or using such rodents, cells from such rodents, and rodent ES cells comprising a humanized PIGR locus.
Owner:REGENERON PHARMACEUTICALS INC

Rodent transport device

The utility model discloses a kind of rodent transport devices, comprising: box body is equipped with partition baffle structure;Partition baffle structure includes multiple baffle;All baffles are blocked in box body as multiple volume equal rodent containing interval;The middle part of each connecting wall body is connected with the baffle of adjacent respectively;Connecting wall body and the two baffle of being connected form containing space;Each food and water storage structure is arranged in a corresponding containing space;All food and water storage structure and all rodent containing interval one-to-one correspondence, and each food and water storage space is provided with opening towards adjacent one rodent containing interval.The utility model sets up multiple independent rodent containing interval in box body by baffle, so that same box body can carry multiple rodents, and avoid mutual pathogen transmission.
Owner:SHANGHAI BEAUTIFUL LIFE MEDICAL TECH CO LTD